Phathom Pharmaceuticals, Inc. — Director's Dealing 2022

Mar 11, 2022

SEC Form 4/A — Form 4/A

Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2022-01-19

Reporting Person: Curran Terrie (Director, President and Chief Executive)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	42955	Direct
Common Stock	724.1	Indirect

Footnotes

F1: On January 21, 2022, the Reporting Person filed a Form 4 (the "Original Form 4") which inadvertently reported incorrect amounts of securities beneficially owned following the transactions reported. Following the transactions reported in the Original Form 4, the Reporting Person (i) directly owns 42,955 shares of Common Stock, which includes 41,250 restricted stock units, and (ii) indirectly owns 724.10 shares of Common Stock through a 401(k) account.